• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.3 -0.1% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Reckitt Benckiser Group share [ISIN: GB00B24CGK77]

01/10/2017 09:27:18 AM
01/10/2017 09:27:18 AM UTC-0500

Reckitt Benckiser Group Plc Buy

The analysts of Société Générale Group S.A. (SG) have rated Reckitt Benckiser Group with a Buy rating. The price target was set to 86.00 £. At a current price of the Reckitt Benckiser Group stock of 67.94 £ this means an upside potential of 26.58%.
Summary: Reckitt Benckiser Group Plc Buy
Company:
Reckitt Benckiser Group Plc
Analyst:
Société Générale Group S.A. (SG)
Price Target:
86.00 £
Current Rating:
Buy
Price*:
79.09 €
Distance to Target Price*:
8.74%
Previous Rating:
-
Latest Price:
67.94 £
Distance Price Target:
26.58%
Analyst Name::
Iain Simpson
P/E Ratio*:
-

News for Reckitt Benckiser Group Plc

More News
  • Relevant
  • All
  • Company News
No news available.

Analyst Opinions for Reckitt Benckiser Group Plc

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/23/17
Reckitt Benckiser Group Barclays Capital
01/20/17
Reckitt Benckiser Group Goldman Sachs Group Inc.
01/17/17
Reckitt Benckiser Group Deutsche Bank AG
01/16/17
Reckitt Benckiser Group UBS AG
01/12/17
Reckitt Benckiser Group JP Morgan Chase & Co.

Add or Edit Instrument

Related Stocks

Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.